Back to Search

AKBA

Akebia Therapeutics, Inc.
Data: 2026-07-14
$1.4
Price
1.45%
Change
$4.04
52W High
$0.82
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Quick Stats
Jul 14, 2026

58.2

AI Score

HOLD

0.47

Volume Ratio

Aug 06, 2026

Next Earnings

20

+ve Days (30d)

9

-ve Days (30d)

AKBA Stock Summary

Last updated Jul 14, 2026

AKBA is currently trading at $1.4, positioned below its 200-day moving average of $1.57, suggesting bearish momentum. The stock has a 52-week range of $0.8227 to $4.04.

Technical Analysis: The 50-day moving average stands at $1.12, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 70.508, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.349, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates AKBA at 58.2/100 with a HOLD recommendation.

AKBA (Akebia Therapeutics, Inc.) Indicators

Last updated Jul 14, 2026

Indicator Value
RSI(14) 70.508
CMF (20) 0.349
ROC (10) 26.126
ADX (14) 35.976
Indicator Value
MACD (12,26,9) 0.093
AROONOSC (14) 64.286
WILLAMS %R (14) -13.953
MFI (14) 80.064
AKBA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

AKBA Price vs Max Options Open Interest
AKBA Max Change In Options Open Interest

AKBA Options - Sort by Max open Interest (near term)

15th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AKBA Daily Out of Money Options - Sort by Max open Interest (near term)

15th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AKBA Daily In the Money Options - Sort by Max open Interest (near term)

15th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AKBA Most Active Options by Volume(near term)

15th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Akebia Therapeutics, Inc. is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).

AKBA Moving Averages Analysis

Akebia Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 14, 2026

AKBA (Akebia Therapeutics, Inc.) Simple Moving Averages

Moving Averages are last updated Jul 14, 2026

Days MA
10 1.33
20 1.19
30 1.11
50 1.12
100 1.25
200 1.57

AKBA Fundamental Analysis

P/E (Forward) 28.7356
P/E (Trailing) --
Market Cap ($) 375.6 million
Earnings/Share ($) -0.08
Net Profit Margin (%) -0.0883
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.105
EPS Estimate Next Year ($) -0.19
WallStreet Target Price ($) 4.20
Most Recent Quarter